========================================
Serotyping Results
========================================
Sample ST: 
[0;32m[2026-02-12 12:36:18][0m STEP 4: Multilocus Sequence Typing (MLST)
[0;34m[INFO][0m Using Abricate v0.9.8 with mlst database
[0;34m[INFO][0m âœ“ MLST analysis completed
[0;34m[INFO][0m   Sequence Type: ST131
ST131
Tools: SerotypeFinder v1.0, FimTyper v1.0
Date: 2026-02-12 12:36:18

O-antigen: O25
  Identity: 100%
  Coverage: 100%

H-antigen: H4
  Identity: 100%
  Coverage: 100%

Complete Serotype: O25:H4

FimH Type: fimH30
  Identity: 100%
  Coverage: 100%

========================================
CLINICAL SIGNIFICANCE
========================================

Serotype O25:H4 + fimH30:
  â€¢ Associated with pandemic 
[0;32m[2026-02-12 12:36:18][0m STEP 4: Multilocus Sequence Typing (MLST)
[0;34m[INFO][0m Using Abricate v0.9.8 with mlst database
[0;34m[INFO][0m âœ“ MLST analysis completed
[0;34m[INFO][0m   Sequence Type: ST131
ST131 clone
  â€¢ Enhanced uroepithelial adherence
  â€¢ Frequently isolated from UTIs worldwide
  â€¢ Correlated with extraintestinal pathogenic E. coli (ExPEC)

Literature References:
  - Commonly reported in clinical UTI isolates
  - Associated with multidrug resistance
  - Part of global epidemiological surveillance targets
